521
Participants
Start Date
May 23, 2016
Primary Completion Date
March 12, 2018
Study Completion Date
March 12, 2018
Insulin glargine/lixisenatide (HOE901/AVE0010)
"Pharmaceutical form: solution~Route of administration: subcutaneous"
Insulin glargine (HOE901)
"Pharmaceutical form: solution~Route of administration: subcutaneous"
Oral anti-diabetic drugs
"Pharmaceutical form: tablet~Route of administration: oral"
Investigational Site Number 392002, Adachi-Ku
Investigational Site Number 392132, Annaka-Shi
Investigational Site Number 392009, Arakawa-Ku
Investigational Site Number 392025, Atsugi-Shi
Investigational Site Number 392024, Chiba
Investigational Site Number 392151, Chiba
Investigational Site Number 392011, Chigasaki-Shi
Investigational Site Number 392013, Chiyoda-Ku
Investigational Site Number 392052, Chiyoda-Ku
Investigational Site Number 392003, Chūōku
Investigational Site Number 392017, Chūōku
Investigational Site Number 392055, Chūōku
Investigational Site Number 392155, Chūōku
Investigational Site Number 392008, Fujimi-Shi
Investigational Site Number 392143, Fujisawa-Shi
Investigational Site Number 392054, Fukuoka
Investigational Site Number 392094, Fukuoka
Investigational Site Number 392147, Fukuoka
Investigational Site Number 392100, Gifu
Investigational Site Number 392059, Hachioji-Shi
Investigational Site Number 392083, Hakodate-Shi
Investigational Site Number 392048, Hamamatsu
Investigational Site Number 392102, Hamamatsu
Investigational Site Number 392079, Hiki-Gun
Investigational Site Number 392112, Hirosaki-Shi
Investigational Site Number 392109, Hofu-Shi
Investigational Site Number 392057, Iruma-Shi
Investigational Site Number 392022, Ise-Shi
Investigational Site Number 392020, Izumisano
Investigational Site Number 392139, Kagoshima
Investigational Site Number 392136, Kamogawa-Shi
Investigational Site Number 392066, Kashiwa-Shi
Investigational Site Number 392045, Kashiwara-Shi
Investigational Site Number 392006, Kasugai-Shi
Investigational Site Number 392053, Kawagoe-Shi
Investigational Site Number 392065, Kawagoe-Shi
Investigational Site Number 392007, Kawaguchi-Shi
Investigational Site Number 392062, Kawaguchi-Shi
Investigational Site Number 392077, Kawasaki-Shi
Investigational Site Number 392082, Kawasaki-Shi
Investigational Site Number 392091, Kawasaki-Shi
Investigational Site Number 392142, Kawasaki-Shi
Investigational Site Number 392133, Kitaazumi-Gun
Investigational Site Number 392129, Kitakyushu-Shi
Investigational Site Number 392041, Kitakyusyu-Shi
Investigational Site Number 392068, Kitakyusyu-Shi
Investigational Site Number 392114, Kitamoto-Shi
Investigational Site Number 392086, Kobe
Investigational Site Number 392044, Koga-Shi
Investigational Site Number 392119, Kokubunji-Shi
Investigational Site Number 392001, Koriyama-Shi
Investigational Site Number 392028, Kumamoto
Investigational Site Number 392092, Kumamoto
Investigational Site Number 392108, Kumamoto
Investigational Site Number 392075, Kure-Shi
Investigational Site Number 392032, Kurume-Shi
Investigational Site Number 392118, Kushiro
Investigational Site Number 392107, Kyoto
Investigational Site Number 392088, Maebashi
Investigational Site Number 392113, Matsumoto-Shi
Investigational Site Number 392122, Minatoku
Investigational Site Number 392076, Misato-Shi
Investigational Site Number 392042, Mito
Investigational Site Number 392078, Mito
Investigational Site Number 392148, Nagano
Investigational Site Number 392026, Nagoya
Investigational Site Number 392101, Nagoya
Investigational Site Number 392128, Nagoya
Investigational Site Number 392131, Nagoya
Investigational Site Number 392134, Nagoya
Investigational Site Number 392154, Naka
Investigational Site Number 392127, Niigata
Investigational Site Number 392050, Niihama-Shi
Investigational Site Number 392115, Ogawa-Machi, Hikigun
Investigational Site Number 392071, Okayama
Investigational Site Number 392095, Onga-Gun
Investigational Site Number 392117, Osaka
Investigational Site Number 392144, Osaka
Investigational Site Number 392040, Oyama-Shi
Investigational Site Number 392084, Saga
Investigational Site Number 392069, Saijo-Shi
Investigational Site Number 392030, Saitama-Shi
Investigational Site Number 392074, Sanda-Shi
Investigational Site Number 392047, Sapporo
Investigational Site Number 392089, Sapporo
Investigational Site Number 392150, Sapporo
Investigational Site Number 392097, Sasebo-Shi
Investigational Site Number 392004, Sendai
Investigational Site Number 392103, Sendai
Investigational Site Number 392070, Shimonoseki-Shi
Investigational Site Number 392034, Shimotsuke-Shi
Investigational Site Number 392110, Shinagawa-Ku
Investigational Site Number 392021, Shinjuku-Ku
Investigational Site Number 392098, Shinjuku-Ku
Investigational Site Number 392037, Shizuoka
Investigational Site Number 392081, Shizuoka
Investigational Site Number 392019, Shobara-Shi
Investigational Site Number 392018, Shunan-Shi
Investigational Site Number 392027, Suita-Shi
Investigational Site Number 392056, Taito-Ku
Investigational Site Number 392146, Takamatsu
Investigational Site Number 392051, Takatsuki-Shi
Investigational Site Number 392061, Tokorozawa-Shi
Investigational Site Number 392111, Tomakomai-Shi
Investigational Site Number 392029, Toyonaka-Shi
Investigational Site Number 392073, Tsu
Investigational Site Number 392063, Ube-Shi
Investigational Site Number 392093, Ube-Shi
Investigational Site Number 392039, Yamato-Shi
Investigational Site Number 392067, Yatsushiro-Shi
Investigational Site Number 392012, Yokohama
Investigational Site Number 392126, Yokohama
Investigational Site Number 392035, Zentsuji-Shi
Lead Sponsor
Sanofi
INDUSTRY